Drug Profile
Research programme: camptothecin-somatostatin conjugate - Biomeasure/Ipsen
Alternative Names: BIM-23A807Latest Information Update: 20 Sep 2011
Price :
$50
*
At a glance
- Originator Ipsen Inc
- Class
- Mechanism of Action Somatostatin receptor 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Small cell lung cancer